Affective vulnerability in substance use disorders

被引:46
|
作者
McHugh, R. Kathryn [1 ,2 ]
Kneeland, Elizabeth T. [1 ,2 ]
机构
[1] McLean Hosp, Div Alcohol & Drug Abuse, 115 Mill St, Belmont, MA 02478 USA
[2] Harvard Med Sch, Dept Psychiat, 25 Shattuck St, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
NATIONAL EPIDEMIOLOGIC SURVEY; POSTTRAUMATIC-STRESS-DISORDER; COMORBID ALCOHOL DEPENDENCE; SOCIAL ANXIETY DISORDER; DISTRESS TOLERANCE; GENDER-DIFFERENCES; PSYCHOLOGICAL DISTRESS; EMOTION REGULATION; DRINKING MOTIVES; NEGATIVE AFFECT;
D O I
10.1016/j.copsyc.2019.01.011
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
Substances of abuse are characterized by their rewarding effects and engagement of reward pathways in the brain. However, these substances also provide rapid relief of negative affect, and thus are highly negatively reinforcing. Accordingly, negative affectivity and other affective vulnerabilities (factors related to the experience of affect) are strongly linked to problematic substance use and substance use disorders. In this review, we provide a critical overview of the literature on affective vulnerabilities in substance use disorders. We discuss how both the experience of affect (e.g. negative affectivity, stress reactivity) and the interpretation of affect (e.g. distress intolerance, anxiety sensitivity) are pertinent to the development, maintenance, and treatment of substance use disorders.
引用
收藏
页码:54 / 58
页数:5
相关论文
共 50 条
  • [41] Decision Making Impairment: A Shared Vulnerability in Obesity, Gambling Disorder and Substance Use Disorders?
    Mallorqui-Bague, Nuria
    Fagundo, Ana B.
    Jimenez-Murcia, Susana
    de la Torre, Rafael
    Banos, Rosa M.
    Botella, Cristina
    Casanueva, Felipe F.
    Crujeiras, Ana B.
    Fernandez-Garcia, Jose C.
    Fernandez-Real, Jose M.
    Fruhbeck, Gema
    Granero, Roser
    Rodriguez, Amaia
    Tolosa-Sola, Iris
    Ortega, Francisco J.
    Tinahones, Francisco J.
    Alvarez-Moya, Eva
    Ochoa, Cristian
    Menchon, Jose M.
    Fernandez-Aranda, Fernando
    PLOS ONE, 2016, 11 (09):
  • [42] Contributions of neuroimmune and gut-brain signaling to vulnerability of developing substance use disorders
    Lucerne, Kelsey E.
    Osman, Aya
    Meckel, Katherine R.
    Kiraly, Drew D.
    NEUROPHARMACOLOGY, 2021, 192
  • [43] Epigenetic regulation of stress responses and vulnerability for affective disorders
    Meaney, Michael J.
    BIOLOGICAL PSYCHIATRY, 2008, 63 (07) : 145S - 145S
  • [44] Epidemiology of substance use and substance use disorders in Germany
    Kuefner, H.
    BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2010, 53 (04) : 271 - 283
  • [45] The use of tiagabine in affective disorders
    Carta, MG
    Hardoy, MC
    Grunze, H
    Carpiniello, B
    PHARMACOPSYCHIATRY, 2002, 35 (01) : 33 - 34
  • [46] Substance Use Disorders Are Psychiatric Disorders
    Balasanova, Alena A.
    AMERICAN JOURNAL OF PSYCHIATRY, 2023, 180 (12): : 918 - 918
  • [47] SOCIAL ANXIETY AND SUBSTANCE ABUSE IN AFFECTIVE-DISORDERS
    PILKONIS, PA
    FELDMAN, H
    HIMMELHOCH, J
    COMPREHENSIVE PSYCHIATRY, 1981, 22 (05) : 451 - 457
  • [48] CHRONIC MEDICAL CONDITIONS IN A SAMPLE OF THE GENERAL-POPULATION WITH ANXIETY, AFFECTIVE, AND SUBSTANCE USE DISORDERS
    WELLS, KB
    GOLDING, JM
    BURNAM, MA
    AMERICAN JOURNAL OF PSYCHIATRY, 1989, 146 (11): : 1440 - 1446
  • [49] Indexing the 'dark side of addiction': substance-induced affective symptoms and alcohol use disorders
    Ehlers, Cindy L.
    Gilder, David A.
    Gizer, Ian R.
    Wilhelmsen, Kirk C.
    ADDICTION, 2019, 114 (01) : 139 - 149
  • [50] Physical illness and affective/substance use disorders: patterns of co-morbidity and treatment implications
    Kelly, B
    Underwood, L
    JOURNAL OF AFFECTIVE DISORDERS, 2006, 91 : S27 - S28